← All organizations
First clinical trial
Nov 1, 2009Last known activity
Feb 1, 2017
Acquired by Medivir on Nov 4, 2016
Timeline
2000s
- Jun 1, 2001
TetraLogic Pharmaceuticals— Founded
2010s
- Nov 4, 2016
Medivir— Acquired By
Drugs by trial phase (12 distinct, 13 trials)
Phase 2 (6 own, 0 via acquisition)
Phase 1 (6 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Alopecia
- Alopecia Areata
- Carcinoma
- Carcinoma, Ovarian Epithelial
- Cystadenocarcinoma, Serous
- Fallopian Tube Neoplasms
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Leukemia
- Leukemia, Myelomonocytic, Acute
- Leukemia, Myelomonocytic, Chronic
- Leukemia, Myelomonocytic, Juvenile
- Lymphoma
- Lymphoma, T-Cell
- Lymphoma, T-Cell, Cutaneous
- Myelodysplastic Syndromes
- Neoplasms
- Ovarian Neoplasms
- Preleukemia
- Psoriasis
- Syndrome
Recent trials (13)
- NCT02587962Lead sponsorPhase 1/Phase 2Feb 1, 2017
- NCT02636244Lead sponsorPhase 2Feb 1, 2017
- NCT02756130CollaboratorPhase 2Jan 1, 2017
- NCT02213861Lead sponsorPhase 2Nov 1, 2014
- NCT02288208Lead sponsorPhase 1Nov 1, 2014
- NCT02147873Lead sponsorPhase 2Jun 1, 2014
- NCT01940172Lead sponsorPhase 1Nov 1, 2013
- NCT01828346Lead sponsorPhase 1/Phase 2Jun 1, 2013
- NCT01646567Lead sponsorPhase 1Sep 1, 2012
- NCT01573780CollaboratorPhase 1Apr 1, 2012
- NCT01433731Lead sponsorPhase 1Nov 1, 2011
- NCT01188499Lead sponsorPhase 1/Phase 2Oct 1, 2010
- NCT00993239Lead sponsorPhase 1Nov 1, 2009
Details
- Founded
- Malvern, PA, US Jun 1, 2001
- Last known activity
- Feb 1, 2017